Atlas Trials

Institut de Cancérologie de Lorraine

62 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Institut de Cancérologie de Lorraine

RecordFirmDate
Impact of Anesthesia Alarm Volume on Mental Workload in Surgical Trainees (NCT07089485)Institut de Cancérologie de Lorraine2026-03-10
Efficacy of the MAEva Program (Meditation, Acceptance, and Commitment to Values) Among Patients Treated For Breast Cancer. (NCT07326800)Institut de Cancérologie de Lorraine2026-02-16
"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents. (NCT07165756)Institut de Cancérologie de Lorraine2025-09-09
Spinal Palliation in Irradiation for Neoplastic Analgesia and Life Quality (NCT06884332)Institut de Cancérologie de Lorraine2025-07-02
Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy for Staff at a Cancer Center (NCT06903104)Institut de Cancérologie de Lorraine2025-03-13
Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Adjuvant Hormone Therapy (NCT06552091)Institut de Cancérologie de Lorraine2024-10-17
Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog) (NCT05538000)Institut de Cancérologie de Lorraine2024-08-01
Adherence to Oral Therapies in Advanced Breast and Prostate Cancers (NCT06435546)Institut de Cancérologie de Lorraine2024-06-04
Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted. (NCT05936034)Institut de Cancérologie de Lorraine2024-01-04
Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination (NCT05935995)Institut de Cancérologie de Lorraine2023-11-28
Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL) (NCT04866680)Institut de Cancérologie de Lorraine2023-01-31
SexoMBC2 Non Interventional Study (NCT05577156)Institut de Cancérologie de Lorraine2022-12-05
Artificial Intelligence to Search for Abnormalities in Ambulatory Cancer Patients (NCT05412420)Institut de Cancérologie de Lorraine2022-08-03
Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC (NCT04766502)Institut de Cancérologie de Lorraine2022-01-11
Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors (NCT05151341)Institut de Cancérologie de Lorraine2021-12-13
Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia (NCT05104099)Institut de Cancérologie de Lorraine2021-11-29
Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal (NCT04511988)Institut de Cancérologie de Lorraine2021-07-17
Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO) (NCT04671485)Institut de Cancérologie de Lorraine2020-12-16
Determination of the Feasibility of Tumoural Somatic Mutations Detection in Blood of Patients With Ovarian Cancer (NCT03881683)Institut de Cancérologie de Lorraine2020-02-21
Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients (NCT03755895)Institut de Cancérologie de Lorraine2019-11-02
Psycho-social Determinant for Sport Practised During Cancer (NCT03919149)Institut de Cancérologie de Lorraine2019-10-09
Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure (NCT03832920)Institut de Cancérologie de Lorraine2019-05-02
Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer (NCT02898376)Institut de Cancérologie de Lorraine2018-12-01
Place of General Medical During Oncology Care Management (NCT03416465)Institut de Cancérologie de Lorraine2018-05-16
Therapeutic Drug Monitoring of BRAF-mutated Advanced Melanoma (NCT03416933)Institut de Cancérologie de Lorraine2018-04-27
Metastatic Breast Carcinoma and Women Sexual Quality of Life (NCT03408769)Institut de Cancérologie de Lorraine2018-03-12
CIrCuLAting Dna ESr1 Gene Mutations Analysis (NCT03318263)Institut de Cancérologie de Lorraine2017-12-07
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery (NCT02997553)Institut de Cancérologie de Lorraine2017-11-29
Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients. (NCT03336177)Institut de Cancérologie de Lorraine2017-10-30

Track Institut de Cancérologie de Lorraine automatically

Every clearance here is in the API, with alerts when new ones post.